Advisornet Financial’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1
Closed -$1K 1786
2019
Q4
$1K Hold
1
﹤0.01% 1732
2019
Q3
$0 Hold
1
﹤0.01% 1856
2019
Q2
$1K Hold
1
﹤0.01% 1564
2019
Q1
$3K Hold
1
﹤0.01% 1365
2018
Q4
$4K Hold
1
﹤0.01% 1261
2018
Q3
$4K Hold
1
﹤0.01% 1301
2018
Q2
$4K Hold
1
﹤0.01% 1307
2018
Q1
$5K Hold
1
﹤0.01% 1207
2017
Q4
$5K Buy
+1
New +$4.57K ﹤0.01% 1104

Other funds holding CANF

Advisornet Financial's CANF Position: Q1 2020 in Review

Advisornet Financial sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2020, closing a stake of 1 share — an estimated $1K sold.

Advisornet Financial first reported a position in CANF in Q4 2017 and held it in 9 quarters. The position peaked at $5K in Q1 2018. 4 funds tracked by Wall St. Rank hold CANF as of Q1 2020.

  • Advisornet Financial reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • Advisornet Financial sold 1 Can-Fite BioPharma American Depositary Shares share in Q1 2020, an estimated $1K.
  • Advisornet Financial first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2017 and held it in 9 quarters.
  • Advisornet Financial's Can-Fite BioPharma American Depositary Shares position peaked at $5K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2020.

Based on Advisornet Financial's 13F filing for Q1 2020, filed 14 May 2020.